The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
RC108 in combination with furmonertinib in patients with locally advanced or metastatic EGFR-mutated non-small-cell lung cancer (NSCLC) with MET overexpression: Results from a phase Ib/II trial.
 
Yutao Liu
No Relationships to Disclose
 
Yongchang Zhang
No Relationships to Disclose
 
Liang Zeng
No Relationships to Disclose
 
Yan Yu
No Relationships to Disclose
 
Bo Pan
No Relationships to Disclose
 
Yongzhong Luo
No Relationships to Disclose
 
Hua Zhong
No Relationships to Disclose
 
Rong Qiao
No Relationships to Disclose
 
Xiangjiao Meng
No Relationships to Disclose
 
Dan Yang
No Relationships to Disclose
 
Jin Cao
No Relationships to Disclose
 
Guixiang Weng
No Relationships to Disclose
 
Shanshan Gu
Employment - RemeGen Co., Ltd.
 
Tianyu Ren
Employment - RemeGen Co., Ltd.
 
Bo Yang
Employment - RemeGen Co., Ltd.
 
Jianmin Fang
Stock and Other Ownership Interests - RemeGen Co., Ltd.
 
Yuankai Shi
No Relationships to Disclose